DrugId:  1
1. Name:  Efatutazone
2. Groups:  Investigational
3. Description:  Efatutazone has been used in trials studying the treatment of Lymphoma, Liposarcoma, Solid Tumors, Multiple Myeloma, and Recurrent Thyroid Cancer, among others.
4. Indication:  Not Available
